Abstract
Positron emission tomography combined with computed tomography (PET/CT) is a nuclear imaging technique which is increasingly being used in infectious diseases. Because infection foci often consume more glucose than surrounding tissue, most infections can be diagnosed with PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose (FDG), an analogue of glucose labeled with Fluorine18. In this review, we discuss common infectious diseases in which FDG-PET/CT is currently applied including bloodstream infection of unknown origin, infective endocarditis, vascular graft infection, spondylodiscitis, and cyst infections. Next, we highlight the latest developments within the field of PET/CT, including total body PET/CT, use of novel PET radiotracers, and potential future applications of PET/CT that will likely lead to increased capabilities for patient-tailored treatment of infectious diseases.
Author supplied keywords
Cite
CITATION STYLE
Pijl, J. P., Kwee, T. C., Slart, R. H. J. A., & Glaudemans, A. W. J. M. (2021, March 1). Pet/ct imaging for personalized management of infectious diseases. Journal of Personalized Medicine. MDPI AG. https://doi.org/10.3390/jpm11020133
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.